Literature DB >> 31053634

Defining the Hallmarks of Metastasis.

Danny R Welch1, Douglas R Hurst2.   

Abstract

Metastasis is the primary cause of cancer morbidity and mortality. The process involves a complex interplay between intrinsic tumor cell properties as well as interactions between cancer cells and multiple microenvironments. The outcome is the development of a nearby or distant discontiguous secondary mass. To successfully disseminate, metastatic cells acquire properties in addition to those necessary to become neoplastic. Heterogeneity in mechanisms involved, routes of dissemination, redundancy of molecular pathways that can be utilized, and the ability to piggyback on the actions of surrounding stromal cells makes defining the hallmarks of metastasis extraordinarily challenging. Nonetheless, this review identifies four distinguishing features that are required: motility and invasion, ability to modulate the secondary site or local microenvironments, plasticity, and ability to colonize secondary tissues. By defining these first principles of metastasis, we provide the means for focusing efforts on the aspects of metastasis that will improve patient outcomes. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31053634      PMCID: PMC6571042          DOI: 10.1158/0008-5472.CAN-19-0458

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  256 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Development of markers of prostate cancer metastasis. Review and perspective.

Authors: 
Journal:  Urol Oncol       Date:  2000-09-01       Impact factor: 3.498

3.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

4.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis.

Authors:  A B Al-Mehdi; K Tozawa; A B Fisher; L Shientag; A Lee; R J Muschel
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

5.  Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line.

Authors:  S Ito; H Nakanishi; Y Ikehara; T Kato; Y Kasai; K Ito; S Akiyama; A Nakao; M Tatematsu
Journal:  Int J Cancer       Date:  2001-07-15       Impact factor: 7.396

Review 6.  Detection and clinical importance of micrometastatic disease.

Authors:  K Pantel; R J Cote; O Fodstad
Journal:  J Natl Cancer Inst       Date:  1999-07-07       Impact factor: 13.506

7.  Quantitation of cell shedding into efferent blood of mammary adenocarcinoma.

Authors:  T P Butler; P M Gullino
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

8.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

Authors:  K Illmensee; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

10.  Relationship of hypoxia to metastatic ability in rodent tumours.

Authors:  K De Jaeger; M C Kavanagh; R P Hill
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

View more
  119 in total

Review 1.  Membrane-core nanoparticles for cancer nanomedicine.

Authors:  Jianfeng Guo; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-22       Impact factor: 15.470

Review 2.  Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.

Authors:  Meng Lan; Wenping Lu; Tengteng Zou; Lihong Li; Fengjie Liu; Tiange Cai; Yu Cai
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 3.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

4.  Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase.

Authors:  Putthaporn Kaewmeesri; Veerapol Kukongviriyapan; Auemduan Prawan; Sarinya Kongpetch; Laddawan Senggunprai
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 5.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

6.  Opportunities for improving cancer treatment using systems biology.

Authors:  Jason I Griffiths; Adam L Cohen; Veronica Jones; Ravi Salgia; Jeffrey T Chang; Andrea H Bild
Journal:  Curr Opin Syst Biol       Date:  2019-11-27

Review 7.  Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications.

Authors:  Neel Rajan; Tilak Khanal; Matthew D Ringel
Journal:  Endocrine       Date:  2020-08-11       Impact factor: 3.633

Review 8.  Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.

Authors:  Sitaram Harihar; Srijit Ray; Samyukta Narayanan; Anirudh Santhoshkumar; Thuc Ly; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2020-02-22       Impact factor: 5.150

Review 9.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 10.  The mechanobiome: a goldmine for cancer therapeutics.

Authors:  Eleana Parajón; Alexandra Surcel; Douglas N Robinson
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.